19 results
DEFA14A
EX-4.1
ALNAQ
Allena Pharmaceuticals, Inc.
4 May 22
Additional proxy soliciting materials
9:09am
DEFA14A
EX-4.2
ALNAQ
Allena Pharmaceuticals, Inc.
4 May 22
Additional proxy soliciting materials
9:09am
8-K
EX-4.2
ALNAQ
Allena Pharmaceuticals, Inc.
4 May 22
Allena Pharmaceuticals Announces $2.8 Million Registered Direct Offering
9:03am
8-K
EX-4.1
ALNAQ
Allena Pharmaceuticals, Inc.
4 May 22
Allena Pharmaceuticals Announces $2.8 Million Registered Direct Offering
9:03am
8-K
EX-4.1
ALNAQ
Allena Pharmaceuticals, Inc.
16 Jul 21
Allena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
4:22pm
8-K
EX-4.2
abny dnlf
16 Jul 21
Allena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
4:22pm
8-K
EX-4.1
bqdz73yybe
1 Oct 20
Allena Pharmaceuticals Announces $25 Million Strategic Convertible Debt Financing Agreement
8:15am
S-3
EX-4.5
agc0cx63 52f
3 Dec 18
Shelf registration
4:36pm
S-3
EX-4.6
2fn8cgn6r8ce2xbxhaqb
3 Dec 18
Shelf registration
4:36pm
S-1/A
EX-4.1
2pha9acnroqk xeh3beb
23 Oct 17
IPO registration (amended)
12:00am
S-1
EX-4.3
qejtk1nqxl4fn1b
6 Oct 17
IPO registration
12:00am
S-1
EX-4.4
l5j9ea
6 Oct 17
IPO registration
12:00am
S-1
EX-4.2
k9vm8e0l
6 Oct 17
IPO registration
12:00am
DRS
EX-4
5zfsib8id 0v3e9eh
18 Aug 17
Draft registration statement
12:00am
DRS
EX-4
p0jbe9pm0
18 Aug 17
Draft registration statement
12:00am
DRS
EX-4
ccx fqyrx2qiooosyhn
18 Aug 17
Draft registration statement
12:00am
- Prev
- 1
- Next